Screening should also assess weight suppression (the difference between a patients maximum and current weight) and consider whether, following weight loss, patients experienced an intense fear of weight gain or symptoms of starvation (e.g., low body temperature, reduced heart rate, preoccupation with thoughts of food, irritability, decreased sexual desire, or social isolation)
Ill have someone who has pre-diabetes, who has sleep apnea, who has COPD and theyre 300, 400 pounds
These factors exist independently of semaglutide and would be present whether or not GLP-1 therapy was part of the treatment plan
Comparison table: fat loss peptide combinations Cost considerations and practical budgeting Running this combination involves ongoing costs that researchers should budget for before committing to a multi-month protocol